Skip to main content
Clinical Trials/TCTR20221004010
TCTR20221004010
Unknown
Phase 1

Effectiveness of Individual and Group Cognitive Behavior Therapy for Patients with Anxiety Disorders

/A0 sites90 target enrollmentOctober 4, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients with anxiety disorder would be included in the study. There is no harm and risk for the participants.
Sponsor
/A
Enrollment
90
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 4, 2022
End Date
March 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • The patient in this study would be diagnosed patients with anxiety disorders would be included. Patients having the ability to read, write and understand will be included.

Exclusion Criteria

  • Patients will diagnose with any other mental disorder would be excluded. The participants who will not complete the post assessment and research procedure would be excluded from study.

Outcomes

Primary Outcomes

Not specified

Similar Trials